Alteration of contractile and regulatory proteins following partial bladder outlet obstruction

Scandinavian Journal of Urology and Nephrology, Supplement

Volumn 38, Issue 215, 2004, Pages 26-36

  Chacko, Samuel ^a   Chang, Shaohua ^a   Hypolite, Joseph A ^a   DiSanto, Michael E ^a   Wein, Alan J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bladder hypertrophy; Bladder obstruction; Ca2+ sensitization; Caldesmon; Myosin isoform; Rho activated kinase; Thick filament; Thin filament

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALDESMON; CONTRACTILE PROTEIN; ENZYME INHIBITOR; MYOSIN ADENOSINE TRIPHOSPHATASE; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; REGULATOR PROTEIN; RHO KINASE; CALMODULIN BINDING PROTEIN; MYOSIN;

ADOLESCENT; ANIMAL TISSUE; BLADDER CONTRACTION; BLADDER DYSFUNCTION; BLADDER NECK STENOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DETRUSOR HYPERTROPHY; DETRUSOR MUSCLE; ENZYME ACTIVITY; GENE OVEREXPRESSION; MUSCLE CELL; MUSCLE FORCE; MUSCLE HYPERTROPHY; MUSCLE RELAXATION; MYOFILAMENT; NONHUMAN; PARTIAL BLADDER NECK STENOSIS; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THIN FILAMENT; WESTERN BLOTTING; ANIMAL; BLADDER OBSTRUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SMOOTH MUSCLE;

ANIMALS; CALMODULIN-BINDING PROTEINS; MUSCLE, SMOOTH; RABBITS; SMOOTH MUSCLE MYOSINS; URINARY BLADDER NECK OBSTRUCTION;

EID: 9244219574     PISSN: 03008886     EISSN: None     Source Type: Journal    
DOI: 10.1080/03008880410015147     Document Type: Conference Paper

References (67)

1. Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: the influence of detrusor under-activity on the outcome after transurethral resection of the prostate with a minimum 10-year urodynamic follow-up. BJU Int 2004; 93: 745-50.
2. Wein AJ. Assessing treatment results in benign prostatic hyperplasia. Urol Clin North Am 1995; 22: 345-55.
3. Elbadawi A. Functional anatomy of the organs of micturition. Urol Clin North Am 1996; 23: 177-210.
4. Zderic SA, Chacko SK, DiSanto ME, Wein AJ. Voiding function: relevant anatomy, physiology, pharmacology, and molecular aspects. In: Gillenwater JY, Grayhack JT, Howards SS, Mitchell ME, editors. Adult and pediatric urology. Philadelphia, PA: Lippincott Williams and Wilkins; 2002. p. 1061-113.
5. Levin RM, Malkowicz SB, Wein AJ, Atta MA, Elbadawi A. Recovery from short-term obstruction of the rabbit urinary bladder. J Urol 1985; 134: 388-90.
6. Buttyan R, Chen MW, Levin RM. Animal models of bladder outlet obstruction and molecular insights into the basis for the development of bladder dysfunction. Eur Urol 1997; 32 (Suppl 1): 32-39.
7. Stein R, Gong C, Hutcheson JC, Canning DA, Zderic SA. The decompensated detrusor III: impact of bladder outlet obstruction on sarcoplasmic endoplasmic reticulum protein and gene expression. J Urol 2000; 164: 1026-30.
8. Kato K, Monson FC, Longhurst PA, Wein AJ, Haugaard N, Levin RM. The functional effects of long-term outlet obstruction on the rabbit urinary bladder. J Urol 1990; 143: 600-6.
9. Wein AJ. Bladder outlet obstruction-an overview. Adv Exp Med Biol 1995; 385: 3-5.
10. Stein R, Hutcheson JC, Krasnopolsky L, Canning DA, Carr MC, Zderic SA. The decompensated detrusor V: molecular correlates of bladder function after reversal of experimental outlet obstruction. J Urol 2001; 166: 651-7.
11. Barany M. ATPase activity of myosin correlated with speed of muscle shortening. J Gen Physiol 1967; 50 (Suppl 218).
12. Adelstein RS, Eisenberg E. Regulation and kinetics of the actin-myosin-ATP interaction. Annu Rev Biochem 1980; 49: 921-56.
13. Babij P, Periasamy M. Myosin heavy chain isoform diversity in smooth muscle is produced by differential RNA processing. J Mol Biol 1989; 210: 673-9.
14. Wang ZE, Gopalakurup SK, Levin RM, Chacko S. Expression of smooth muscle myosin isoforms in urinary bladder smooth muscle during hypertrophy and regression. Lab Invest 1995; 73: 244-51.
15. Cher ML, Abernathy BB, McConnell JD, Zimmern PE, Lin VK. Smooth-muscle myosin heavy-chain isoform expression in bladder-outlet obstruction. World J Urol 1996; 14: 295-300.
16. Pyne GJ, Martin AF, Paul RJ. Role of C-terminal myosin heavy chain isoforms in smooth muscle function: evidence from mice overexpressing SMaSM1 (Abstract). Biophysical Journal 2002; 82: 1735.
17. Rovner AS, Fagnant PM, Lowey S, Trybus KM. The carboxyl-terminal isoforms of smooth muscle myosin heavy chain determine thick filament assembly properties. J Cell Biol 2002; 156: 113-23.
18. Babij P, Kelly C, Periasamy M. Characterization of a mammalian smooth muscle myosin heavy-chain gene: complete nucleotide and protein coding sequence and analysis of the 5′ end of the gene. Proc Natl Acad Sci USA 1991; 88: 10676-80.
19. Babij P. Tissue-specific and developmentally regulated alternative splicing of a visceral isoform of smooth muscle myosin heavy chain. Nucleic Acids Res 1993; 21: 1467-71.
20. Kelley CA, Takahashi M, Yu JH, Adelstein RS. An insert of seven amino acids confers functional differences between smooth muscle myosins from the intestines and vasculature. J Biol Chem 1993; 268: 12848-54.
21. 2-terminal-inserted myosin II heavy chain is expressed in smooth muscle of small muscular arteries. Am J Physiol 1997; 272: C1532-42.
22. Babu GJ, Loukianov E, Loukianova T, Pyne GJ, Huke S, Osol G, et al. Loss of SM-B myosin affects muscle shortening velocity and maximal force development. Nat Cell Biol 2001; 3: 1025-9.
23. Siegman MJ, Butler TM, Mooers SU, TrinkleMulcahy L, Narayan S, Adam L, et al. Colonic smooth muscle: contractile proteins, shortening velocity, and regulation. Am J Physiol Gastrointest Liver Physiol 1997; 35: G1571-80.
24. Hypolite JA, DiSanto ME, Zheng Y, Chang S, Wein AJ, Chacko S. Regional variation in myosin isoforms and phosphorylation at the resting tone in urinary bladder smooth muscle. Am J Physiol Cell Physiol 2001; 280: C254-64.
25. Hartshorne DJ. Physiology of the gastrointestinal tract. New York: Raven; 1987. p. 423-82.
26. Am J Physiol Renal Physiol 2003; 285: F990-7.
27. Lenz S, Lohse P, Seidel U, Arnold HH. The alkali light chains of human smooth and nonmuscle myosins are encoded by a single gene. Tissue-specific expression by alternative splicing pathways. J Biol Chem 1989; 264: 9009-15.
28. Nabeshima Y, Nonomura Y, Fujii-Kuriyama Y. Non-muscle and smooth muscle myosin light chain mRNAs are generated from a single gene by the tissue-specific alternative RNA splicing. J Biol Chem 1987; 262: 10608-12.
29. Hasegawa Y, Ueno H, Horie K, Morita F. Two isoforms of 17-kDa essential light chain of aorta media smooth muscle myosin. J Biochem 1988; 103: 15-8.
30. Matthew JD, Khromov AS, Trybus KM, Somlyo AP, Somlyo AV. Myosin essential light chain isoforms modulate the velocity of shortening propelled by non-phosphorylated cross-bridges. J Biol Chem 1998; 273: 31289-96.
31. DiSanto ME, Stein R, Chang S, Hypolite JA, Zheng Y, Zderic S, et al. Alteration in expression of myosin isoforms in detrusor smooth muscle following bladder outlet obstruction. Am J Physiol Cell Physiol 2003; 285: C1397-410.
32. Sjuve R, Haase H, Morano I, Uvelius B, Arner A. Contraction kinetics and myosin isoform composition in smooth muscle from hypertrophied rat urinary bladder. J Cell Biochem 1996; 63: 86-93.
33. 2+ regulation. Proc Natl Acad Sci USA 1977; 74: 129-33.
34. Chacko SK, DiSanto M, Wein AJ. Changes in the composition of myosin isoforms in smooth muscle hypertrophy following urinary bladder outlet obstruction. Advances in Organ Biology 2000; 8: 81-100.
35. Hartshorne DJ, Persechini AJ. Phosphorylation of myosin as a regulatory component in smooth muscle. Ann NY Acad Sci 1980; 356: 130-41.
36. Sellers JR, Pato MD, Adelstein RS. Reversible phosphorylation of smooth muscle myosin, heavy meromyosin, and platelet myosin. J Biol Chem 1981; 256: 13137-42.
37. Butler TM, Siegman MJ. Chemical energetics of contraction in mammalian smooth muscle. Fed Proc 1982; 41: 204-8.
38. Dillon PF, Aksoy MO, Driska SP, Murphy RA. Myosin phosphorylation and the cross-bridge cycle in arterial smooth muscle. Science 1981; 211: 495-7.
39. Kamm KE, Stull JT. Myosin phosphorylation, force, and maximal shortening velocity in neurally stimulated tracheal smooth muscle. Am J Physiol 1985; 249: C238-47.
40. Kitazawa T, Masuo M, Somlyo AP. G protein-mediated inhibition of myosin light-chain phosphatase in vascular smooth muscle. Proc Natl Acad Sci USA 1991; 88: 9307-10.
41. 2+ sensitivity of force, but not of MLC phosphorylation, in bladder smooth muscle. Am J Physiol Renal Physiol 2003; 285: F703-10.
42. Kawano Y, Fukata Y, Oshiro N, Amano M, Nakamura T, Ito M, et al. Phosphorylation of myosin-binding subunit (MBS) of myosin phosphatase by Rho-kinase in vivo 1. J Cell Biol 1999; 147: 1023-38.
43. Kawano Y, Yoshimura T, Kaibuchi K. Smooth muscle contraction by small GTPase Rho 1. Nagoya J Med Sci 2002; 65: 1-8.
44. Krueger JK, Gallagher SC, Zhi G, Geguchadze R, Persechini A, Stull JT, Trewhella J. Activation of myosin light chain kinase requires translocation of bound calmodulin 1. J Biol Chem 2001; 276: 4535-8.
45. Hartshorne DJ, Hirano K. Interactions of protein phosphatase type 1, with a focus on myosin phosphatase. Mol Cell Biochem 1999; 190: 79-84.
46. Somlyo AP, Wu X, Walker LA, Somlyo AV. Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol 1999; 134: 201-34.
47. Marston SB, Redwood CS. The molecular anatomy of caldesmon. Biochem J 1991; 279: 1-16.
48. Bryan J, Imai M, Lee R, Moore P, Cook RG, Lin WG. Cloning and expression of a smooth muscle caldesmon. J Biol Chem 1989; 264: 13873-9.
49. Sobue K, Muramoto Y, Fujita M, Kakiuchi S. Purification of a calmodulin-binding protein from chicken gizzard that interacts with F-actin. Proc Natl Acad Sci USA 1981; 78: 5652-5.
50. Mabuchi K, Wang CL. Electron microscopic studies of chicken gizzard caldesmon and its complex with calmodulin. J Muscle Res Cell Motil 1991; 12: 145-51.
51. 2-terminal region of skeletal F-actin. J Biol Chem 1990; 265: 2231-7.
52. Wang Z, Yang ZQ, Chacko S. Functional and structural relationship between the calmodulin-binding, actin-binding, and actomyosin-ATPase inhibitory domains on the C terminus of smooth muscle caldesmon. J Biol Chem 1997; 272: 16896-903.
53. Sobue K, Takahashi K, Wakabayashi I. Caldesmon150 regulates the tropomyosin-enhanced actin-myosin interaction in gizzard smooth muscle. Biochem Biophys Res Commun 1985; 132: 645-51.
54. Horiuchi KY, Miyata H, Chacko S. Modulation of smooth muscle actomyosin ATPase by thin filament associated proteins. Biochem Biophys Res Commun 1986; 136: 962-8.
55. Shirinsky VP, Biryukov KG, Hettasch JM, Sellers JR. Inhibition of the relative movement of actin and myosin by caldesmon and calponin. J Biol Chem 1992; 267: 15886-92.
56. Chalovich JM, Sen A, Resetar A, Leinweber B, Fredricksen RS, Lu F, Chen YD. Caldesmon: binding to actin and myosin and effects on elementary steps in the ATPase cycle. Acta Physiol Scand 1998; 164: 427-35.
57. Lee YH, Gallant C, Guo H, Li Y, Wang CA, Morgan KG. Regulation of vascular smooth muscle tone by N-terminal region of caldesmon. Possible role of tethering actin to myosin. J Biol Chem 2000; 275: 3213-20.
58. Barley JJ, Su X, Moreland RS. Caldesmon inhibits active crossbridges in unstimulated vascular smooth muscle: an antisense oligodeoxynucleotide approach. Circ Res 1998; 83: 661-7.
59. Gerthoffer WT, Yamboliev IA, Shearer M, Pohl J, Haynes R, Dang S, et al. Activation of MAP kinases and phosphorylation of caldesmon in canine colonic smooth muscle. J Physiol 1996; 495: 597-609.
60. Dabrowska R, Goch A, Galazkiewicz B, Osinska H. The influence of caldesmon on ATPase activity of the skeletal muscle actomyosin and bundling of actin filaments. Biochim Biophys Acta 1985; 842: 70-5.
61. ++/calmodulin and to actin or actin-tropomyosin filaments. Cell Motil Cytoskeleton 1991; 20: 95-108.
62. Helfman DM, Levy ET, Berthier C, Shtutman M, Riveline D, Grosheva I, et al. Caldesmon inhibits nonmuscle cell contractility and interferes with the formation of focal adhesions. Mol Biol Cell 1999; 10: 3097-112.
63. Zhang EY, Stein R, Chang S, Zheng Y, Zderic SA, Wein AJ, Chacko S. Smooth muscle hypertrophy following partial bladder outlet obstruction is associated with overexpression of non-muscle caldesmon. Am J Pathol 2004; 164: 601-12.
64. Horiuchi KY, Chacko S. Effect of unphosphorylated smooth muscle myosin on caldesmon-mediated regulation of actin filament velocity. J Muscle Res Cell Motil 1995; 16: 11-9.
65. Horiuchi KY, Chacko S. Caldesmon inhibits the cooperative turning-on of the smooth muscle heavy meromyosin by tropomyosin-actin. Biochemistry 1989; 28: 9111-6.
66. Kim YS, Wang Z, Levin RM, Chacko S. Alterations in the expression of the beta-cytoplasmic and the gamma-smooth muscle actins in hypertrophied urinary bladder smooth muscle. Mol Cell Biochem 1994; 131: 115-24.
67. Yamashiro-Matsumura S, Matsumura F. Characterization of 83-kilodalton nonmuscle caldesmon from cultured rat cells: stimulation of actin binding of nonmuscle tropomyosin and periodic localization along microfilaments like tropomyosin. J Cell Biol 1988; 106: 1973-83.